IQVIA
IQV
$233.98
Share price
-2.85%
Change (1 day)
22.05%
Change (1 year)
IQVIA (IQV) - Cash on Hand
Cash on Hand as of December 2023 : $1.49 B
According to IQVIA's latest financial reports the company has $1.49 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
IQVIA - Cash on Hand chart (from 2012 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $1.49 B | 14.29% |
| 2022-12-31 | $1.30 B | -11.37% |
| 2021-12-31 | $1.47 B | -22.34% |
| 2020-12-31 | $1.90 B | 111.57% |
| 2019-12-31 | $0.89 B | -4.16% |
| 2018-12-31 | $0.93 B | -6.67% |
| 2017-12-31 | $1.00 B | -18.82% |
| 2016-12-31 | $1.23 B | 26.71% |
| 2015-12-31 | $0.97 B | 12.64% |
| 2014-12-31 | $0.86 B | 11.47% |
| 2013-12-31 | $0.77 B | 37.06% |
| 2012-12-31 | $0.56 B | 9.96% |
| 2011-12-31 | $0.51 B |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Nymox Pharmaceutical NYMX | $0.13 M | -99.99% | Bahamas |
 NRC Health
NRC | $6.65 M | -99.56% | 🇺🇸 USA |